Throughout our "Collaborations That Transform" rare disease series, we have seen countless examples of rare disease R&D breakthroughs resulting from great partnerships and global collaboration. Spinal Muscular Atrophy is a rare disease community, which holds no exception to this trend.
Over 560 colleagues and friends registered for the premier on August 20th. Watch to see three panels of distinguished SMA experts, representing patient, industry and physician perspectives. They discussed their unique experiences, challenges, successes and their next steps towards furthering treatments to benefit SMA patients around the world.
Lastly, a thank you to our partners, BioCentury, Children’s Tumor Foundation, CLSA, Informa, New England Hemophilia Association and UK Bioindustry Association for their great support, and to everyone who participated and tuned in. We invite you to be on the lookout for our next "Collaborations That Transform" webinar series on the rare disease Multiple Sclerosis.